Post-market Review Products Used in the Management of Diabetes Report to Government Stage 2: Insulin Pumps February 2015

References

Abaci A, Atas A, et al. 2009, ‘A Comparison of Multiple Daily Insulin Therapy with Continuous Subcutaneous Insulin Infusion Therapy in Adolescents with Type 1 Diabetes Mellitus: A Single-Center Experience From Turkey’, Journal of Pediatric Endocrinology & Metabolism, Vol. 22, No. 6, pp. 539-545.

Aberle I, Zimprich D, et al. 2008, ‘Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control’, Diabetes, Obesity and Metabolism, Vol. 10, No. 4, pp. 329-335.

American Association of Diabetes Educators (AADE), 2008, Insulin pump therapy: guidelines for successful outcomes, American Association of Diabetes Educators 2008 Consensus Summit, Chicago, Illinois.

Animas Corporation, 2012, Get to know the Animas® VibeTM insulin pump and CGM system.

Australian Bureau of Statistics (ABS), 2012, Average Weekly Earnings, Cat. No. 6302.0, Canberra, accessed 12 March 2013.

ABS, 2013, Australian Health Survey: Updated Results, 2011-12 diabetes mellitus, Cat. No. 4364.0.55.003, Canberra, accessed 28 November 2013.

Australian Diabetes Society, 2009, Australian Diabetes Society Position Statement: Individualization of HbA1c Targets for Adults with Diabetes Mellitus.

Australian Institute of Health and Welfare (AIHW), 2008, Diabetes Australian Facts 2008, Canberra.

AIHW, 2011, Prevalence of Type 1 diabetes in Australian children, 2008, Canberra.

AIHW, 2012a, Diabetes among young Australians, Diabetes Series no. 18. Cat. no. CVD 59, Canberra.

AIHW, 2012b, Insulin pump use in Australia, Diabetes series no.18. Cat. no. CVD 58, Canberra.

AIHW, 2013a, Prevalence of diabetes, Canberra, accessed 15 October 2014.

AIHW, 2013b, Diabetes deaths, Canberra, access 15 October 2014.

Australian Tax Office, 2013, Medicare levy surcharge, Canberra, accessed 28 November 2013.

Barnard KD, Lloyd CE & Skinner TC, 2007, ‘Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes’, Diabetic Medicine, Vol. 24, No. 6, pp. 607-17.

Berghaeuser MA, Kapellen T, et al. 2008, ‘Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria’, Pediatric Diabetes, Vol. 9, No. 6, pp. 590-595.

Bismuth E, Bouche C, et al. 2012, ‘Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Societe francophone du diabete [SFD])’, Diabetes & Metabolism, Vol. 38, No. 3, pp. 205-216.

Borg R, Kuenen JC, et al. 2011, ‘HbA_1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with type 1 diabetes: the A1C-Derived Average Glucose (ADAG) study’, Diabetologica, Vol. 54, pp. 69-72.

Bruttomesso D, Crazzolara D, et al. 2008, ‘In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine’, Diabetic Medicine, Vol. 25, No. 3, pp. 326-332.

Bruttomesso D, Bonomo M, et al. 2011, ‘Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)’, Diabetes & Metabolism, Vol. 37, pp. 426-31.

Campbell S, Suebwongpat A, Standfied L & Weston A, 2008, ‘Systematic review update and economic evaluation for the New Zealand setting: Subcutaneous insulin pump therapy’, HSAC Report, Vol. 1, No. 3.

Çamurdan MO, Bideci A, Demirel F & Cinaz P, 2008, ‘The follow-up results of insulin pump use in Turkisch children with type 1 diabetes mellitus’, Gazi Medical Journal, Vol. 19, No. 1, pp. 10-14.

Carlsson BM, Attvall S, et al. 2013, ‘Insulin Pump-Long-Term Effects on Glycemic Control: An Observational Study at 10 Diabetes Clinics in Sweden’, Diabetes Technology & Therapeutics, Vol. 15, No. 4, pp. 302-307.

Cavalot F, 2013, ‘Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes’, Diabetes, Obesity and Metabolism, Vol. 15, No 2, pp. 3-8.

Clar C, Barnard K, et al. 2010, ‘Self-monitoring of blood glucose in type 2 diabetes: systematic review’, Health Technology Assessment Vol. 14, No. 12, pp. 1-140.

Closing the Loop Pty Ltd, 2010, mylife Omnipod, accessed 13 November 2013.

Chen R, Ben-Haroush A, et al. 2007, ‘Level of glycaemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily injections and continuous subcutaneous insulin infusions’, American Journal of Obstetrics & Gynaecology, Vol. 197, No. 4, pp. 404.e1-5.

Chico A, Saigi I, et al. 2010, ‘Glycaemic Control and Perinatal Outcomes of Pregnancies Complicated by Type 1 Diabetes: Influence of Continuous Subcutaneous Insulin Infusion and Lispro Insulin’, Vol. 12, No. 12, pp. 937-45.

Cohen N, Minshall M, et al. 2007, ‘Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: Economic comparison in adult and adolescent type 1 diabetes mellitus in Australia’, Pharmacoeconomics, Vol. 25, pp. 881-97.

Cohen ND, Hong ES, et al. 2013, ‘Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes’, Diabetes Technology & Therapeutics, Vol. 15, No. 7, pp. 544-549.

Craig ME, Twigg SM, et al. 2011, ‘National evidence‐based clinical care guidelines for type 1 diabetes in children, adolescents and adults’, Australian Government Department of Health and Ageing, Canberra.

Cummins E, Royle P, et al. 2010, ‘Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation’, Health Technology Assessment, Vol. 14, No. 11, pp. 1-181.

Cyganek K, Hebda-Szydlo A, et al. 2010, ‘Glycaemic control and selected preganancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injecton: the significance of preganancy planning’, Diabetes Technology & Therapuetics, Vol. 12, No. 1, pp. 41-7.

DeVries JH, Snoek FJ, et al. 2002, ‘A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes patients with long-standing poor glycaemic control’, Diabetes Care, Vol. 25, No. 11, pp. 2074-80.

Diabetes Australia, 2008, Insulin, accessed 13 March 2013.

Diabetes Australia, 2010, Hypoglycaemia factsheet, accessed 13 March 2013.

Diabetes Australia, 2012, Gestational diabetes fact sheet, accessed 20 November 2012.

Diabetes Australia – Victoria, 2009, I’m considering an insulin pump, accessed 13 March 2013.

Diabetes Queensland, 2009, I’m considering an insulin pump, accessed 13 March 2013.

Department of Health, 2010, Prostheses List: Guide to listing and setting benefits for prostheses – Part 1 – Understanding the Prostheses Arrangements, accessed 17 July 2013.

Department of Health, 2013a, Pharmaceutical Benefits Advisory Committee Guidelines – Version 4.3, Department of Health, pg. 3.

Department of Health, 2014, Prostheses List , accessed 26 February 2014.

Department of Human Services, 2013a, Income test for Family Tax Benefit Part A, accessed 28 November 2013.

Department of Human Services, 2013b, Eligibility for a Health Care Card, accessed 28 November 2013.

Diabetes Control and Complications Trial Research Group, 1995, ‘Resource Utilization and Costs of Care in the Diabetes Control and Complications Trial’, Diabetes care, Vol. 18, No. 11, pp. 1468-78.

Farmer AJ, Perera R, et al. 2012, ‘Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes’, British Medical Journal, Vol. 344, e486.

Farrar D, Tuffnell D & West J, 2007, 'Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes', Cochrane Database of Systematic Reviews 2007, Issue 3.

Fatourechi, MM, Kudva YC, et al. 2009, ‘Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections’, Journal of Clinical Endocrinology & Metabolism, Vo. 94, No. 3, pp. 729-740.

Fendler W, Baranowska AI, et al. 2012, ‘Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes’, Acta Diabetologica, Vol. 49, No. 5, pp. 363-370.

Fosket D & Price DA, 2011, ‘An overview of insulin pump therapy’, Medicine Today, Vol. 11, No. 12.

Gabbe SG, Holing E, Temple P and Brown ZA, 2000, ‘Benefits, risks, costs, and patient satisfation associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus‘, American Journal of Obstetrics & Gynecology, Vol. 182, No. 6, pp. 1283-90.

Giacco F & Brownlee M, 2010, ‘Oxidative stress and diabetic complications’, Circulation Research, Vol. 29, No. 9, pp. 1058-70.

Gimenez M, Lara M & Conget I, 2010, ‘Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study’, Diabetes Technology and Therapeutics, Vol. 12, No. 7, pp. 517-521.

Gonzalez-Romero S, Gonzalez-Molero I, et al. 2010, ‘Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes’, Diabetes Technology and Therapeutics, Vol. 12, No. 4, pp. 263-269.

Gordin D, Ronnback M, et al. 2008, ‘Glucose variability, blood pressure and arterial stiffness in type 1 diabetes’, Diabetes Research & Clinical Practice, Vol. 80, No. 3, pp. e4-7.

Grunberger G, Bailey TS, et al. 2010, ‘Statement by the American Association of Clinical Endocrinologists consensus panel on insulin pump management’, Endocrine Practice, Vol. 16, No. 5, pp. 746-762.

Guinn TS, Bailey GJ & Mecklenberg RS, 1988, ‘Factors related to discontinuation of continuous subcutaneous insulin infusion therapy’, Diabetes Care, Vol. 11, No. 1, pp. 4651.

Hasanbegovic S, & Hasanbegovic E, 2009, ‘Metabolic Control of Type 1 Diabetes in Children Treated with Insulin Pump Therapy’, Bosnian Journal of Basic Medical Sciences, Vol. 9, No. 2, pp. 120-124.

Heinemann L, 2009, ‘Insulin Pump Therapy: What is the evidence for using different types of boluses for coverage of prandial insulin requirements?’, Journal of Diabetes Science & Technology, Vol. 3, No. 6, pp. 1490-1500.

Hoogma R, Hammond PJ, et al. 2006, ‘Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial’, Diabetic Medicine, Vol. 23, No. 2, pp. 141-147.

Hughes CR, McDowell N, Cody D & Costigan C, 2012, ‘Sustained benefits of continuous subcutaneous insulin infusion’, Archives of Disease in Childhood, Vol. 97, No. 3, pp. 245-247.

International Diabetes Federation-European Region (IDF Europe), the Foundation of European Nurses in Diabetes (FEND), the Primary Care Diabetes Europe (PCDE) and the European Alliance for Research in Diabetes (EURADIA), 2011, Diabetes - The Policy Puzzle, 3^rd Edition, Europe.

Jakisch BI, Wagner VM, et al. 2008, ‘Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years’, Diabetic Medicine, Vol. 25, No. 1, pp. 80-85.

Johnson SR, Cooper MN, Jones TW & Davis EA, 2013, ‘Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study’, Diabetologia, Vol. 56, No. 11, pp. 2392-400.

Juvenile Diabetes Research Foundation (JDRF), 2013, End of Programme Report, Canberra.

Kallas-Koeman MM, Kong JM, et al. 2014, ‘Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes’, Diabetologia, Vol. 57, No. 4, pp. 681-689.

Knight SJ, Northam EA, Cameron FJ & Ambler GR, 2011, ‘Behaviour and metabolic control in children with Type 1 diabetes mellitus on insulin pump therapy: 2-year follow-up’, Diabetic Medicine, Vol. 28, No. 9, pp. 1109-1112.

Lange K, Jackson C & Deeb L, 2009, ‘Diabetes Care in School, the Disturbing Facts’, Pediatric Diabetes, Vol. 10, pp. 28-36.

Lepore G, Bruttomesso D, et al. 2009, ‘Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients’, Diabetic Medicine, Vol. 26, No. 6, pp. 602-608.

Levy-Shraga Y, Lerner-Geva L, et al. 2013, ‘Benefits of Continuous Subcutaneous Insulin Infusion (CSII) Therapy in Preschool Children’, Experimental and Clinical Endocrinology & Diabetes, Vol. 121, No. 4, pp. 225-229.

Lin CH, Huang CH, et al. 2011, ‘Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan’, Endocrine Journal, Vol. 58, No. 10, pp. 835-840.

Ly TT, Nicholas JA, et al. 2013, 'Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes', The Journal of the American Medical Association, Vol. 310, No.12, pp. 1240-1247.

Marks A, Wilson V & Crisp J, 2013, ‘The Management of Type 1 Diabetes in Primary School: Review of the Literature’, Issues in Comprehensive Pediatric Nursing, Vol. 36, No. 1-2, pp. 98-119.

Marks A, Wilson V & Crisp J, 2014, ‘The Management of Type 1 Diabetes in Australian Primary Schools’, Issues in Comprehensive Pediatric Nursing, Vol. 37, No. 3, pp. 168-82.

Marmolin ES, Brodsgaard J, et al. 2012, ‘Better treatment of outpatients with type 1 diabetes after introduction of continuous subcutaneous insulin infusion’, Danish Medical Journal, Vol. 59, No. 6, A4445.

Medtronic MiniMed Inc., 2009, The MiniMed Paradigm® Veo^TM System: Live More, Worry Less, Europe.

Middlehurst A & Morrison M, 2008, Diabetes Management in the School Setting. A NSW parent survey, Diabetes Australia (unpublished).

Misso ML, Egberts KJ, et al. 2010, ‘Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus’, Cochrane Database of Systematic Reviews, Issue 1.

Monami M, Lamanna C, Marchionni N & Mannucci E, 2010, ‘Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis’, Acta Diabetologica, Vol. 47, Supplement 1, pp. 77-81.

Mukhopadhyay A, Farrell T, Fraser RB & Ola B, 2007, ‘Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis of randomized, controlled trials’, American Journal of Obstetrics & Gynecology, Vol. 197, No. 5, pp. 447-456.

Nalysnyk L, Hernandez-Medina M & Krishnarajah G, 2010, ‘Glycaemic variability and complications in patients with diabetes mellitus; evidence from a systematic review of the literature’, Diabetes, Obesity and metabolism 12: pp. 288-298.

National Institute for Health and Clinical Excellence (NICE), 2009, Insulin pump therapy service for people with diabetes, Commissioning guide, implementing NICE guidance, accessed 6 March 2013.

National Health and Medical Research Council (NHMRC), 2011, About the clinical practice guidelines portal, accessed 8 March 2013.

Neff KJ, Forde R, et al. 2014, ‘Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy’, Irish Journal of Medical Science, Vol. 183, No. 3, pp. 387-403.

New Zealand Society for the Study of Diabetes (NZSSD), 2008, NZSSD Position Statement on Insulin Pump Therapy, accessed 8 March 2013.

NPS Medicinewise, 2013, Insulin pumps for type 1 diabetes, accessed 19 November 2013.

O’Connell MA & Cameron FJ, 2008, ‘Practical experience with continuous subcutaneous insulin infusion therapy in pediatric diabetes clinic’, Journal of Diabetes Science and Technology, Vol. 2, No. 1, pp. 91-97.

Palmer AJ, Roze WJ, et al. 2004, ‘The CORE Diabetes Model: Projecting long-term clinical outcomes, costs, and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making’, Current Medical research and Opinion, Vol. 20 (Supplement), pp. 5-26.

Pearson DW, Kernaghan D, et al. 2007, ‘The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type 1 diabetes mellitus’, BJOG, Vol. 114, No. 1, pp. 447-456.

Pena AS, Couper JJ, et al. 2012, ‘Hypoglycaemia, but not glucose variability, relates to vascular function in children with type 1 diabetes’, Diabetes Technology & Therapeutics, Vol. 14, No. 6, pp. 457-61.

PHARMAC, 2012, PHARMAC Memorandum for Board Meeting of 29 June 2012: Listing of New Zealand Medical and Scientific Insulin pump and consumables, accessed 23 October 2014.

PHARMAC, 2014, Online Pharmaceutical Schedule Section B – Therapeutic Groups: Insulin Pumps, accessed 23 October 2014.

Pickup JC, 2012, 'Insulin-Pump Therapy for Type 1 Diabetes Mellitus', The New England Journal of Medicine, Vol. 366, No.17, pp.1616-1624.

Pickup JC & Renard E, 2008, ‘Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes’, Diabetes Care, Vol. 31, Suppl. 2, pp. S140–S145.

Private Health Insurance Ombudsman, 2014, ‘Compare private health insurance policies’ website.

Rabbone I, Scaramuzza A, et al. 2009, ‘Insulin Pump Therapy Management in Very Young Children with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion’, Diabetes Technology & Therapeutics, Vol. 11, No. 11, pp. 707-709.

Retnakaran R, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V & Zinman B, 2005, ‘Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: Modelling predicted benefits in relationship to baseline A_1c’. Diabetes Care, Vol. 28, No. 7, pp. 18356.

Saudek CD & Brick JC, 2009, ‘The clinical use of haemoglobin A1c’, Journal of Diabetes Science and Technology, Vol. 3, No. 2, pp. 629-34.

Schwartz FL, Denham S, et al. 2010, Lifestyle and behaviour. Experiences of Children and Adolescents with Type 1 Diabetes in School: Survey of Children, Parents and Schools, Diabetes Spectrum, Vol. 23, pp. 47-55.

Scottish Intercollegiate Guidelines Network (SIGN), 2010, Management of diabetes. A national clinical guideline, Edinburgh.

Scuffham P & Carr L, 2003, ‘The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injection for the management of diabetes’, Diabetic Medicine, Vol. 20, No. 7, pp. 586-93.

Senniappan SP, Hine W, et al. 2012, ‘The effect of socioeconomic deprivation on efficacy of continuous subcutaneous insulin infusion: a retrospective paediatric case-controlled study’, European Journal of Pediatrics, Vol. 171, No. 1, pp. 59-65.

Shalitin S & Phillip M, 2008, ‘The use of insulin pump therapy in the pediatric age group’, Hormone Research, Vol. 70, pp. 14-21.

Shalitin S, Gil M, et al. 2010, ‘Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy’, Diabetic Medicine, Vol. 27, No. 3, pp. 339-347.

Shaw JE & Chisholm DJ, 2003, ‘1: Epidemiology and prevention of type 2 diabetes and the metabolic syndrome’, Medical Journal of Australia, Vol. 179, No. 7, pp. 379-383.

St Charles ME, Sadri H, Minshall ME & Tunis SL, 2009, ‘Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada’, Clinical therapeutics, Vol. 31, No. 3, pp. 657-67.

St-Hilaire C & Côté B, 2005, Agence d'évaluation des technologies et des modes d'intervention en santé, ‘Comparison of the insulin pump and multiple daily insulin injections in intensive therapy for type 1 diabetesI’, [Montréal]: Agence d'évaluation des technologies et des modes d'intervention en santé.

Tamborlane WV & Sherr JL, 2013, ‘Insulin pumps in children with T1DM—we told you so’, Nature Reviews Endocrinology, Vol. 9, pp. 629–630.

The Diabetes Control and Complications Trial Research Group, 1988, ‘Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT)’, Diabetes Care, Vol. 11, No. 9, pp. 725-32.

U.S. Department of Health and Human Services, 2012, Medicare's Coverage of Diabetes Supplies and Services, Maryland.

Victorian CSII Working Party, 2009, Guidelines for Continuous Subcutaneous Insulin Infusion (CSII) Pump Therapy (Version 1 – July 2009), Melbourne.

Wenholt IM, Kulik W, et al. 2008, ‘Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes’, Diabetologica, Vol. 51, No. 1, pp. 183-90.

World Health Organization (WHO) and International Diabetes Federation, 2006, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Issue 5: What diagnostic tests should be used to define glycaemic status, Geneva.

WHO, 2011, Use of Glycated Haemoglobin (HbA_1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation, Geneva.

WHO, 2013, Diabetes fact sheet No. 312, Geneva, accessed 12 November 2013.

Yeh HC, Brown TT, Maruther N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass ED & Golden SH, 2012, ‘Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis’ Annals of Internal Medicine, Vol. 157, No. 5, pp. 336-47.

Yorkshire and Humbler Public Health Observatory, 2008, Diabetes Attributable Deaths: Estimating the excess deaths among people with diabetes, United Kingdom, accessed 29 January 2014.